1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,380 | 3,540 | 16:06 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:19 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
| 13.11. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 05.11. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 28.10. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 25.10. | HAOHAI BIOTEC (06826): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
| 25.10. | HAOHAI BIOTEC (06826): WORKING RULES OF THE STRATEGY AND SUSTAINABLE DEVELOPMENT COMMITTEE OF THE BOARD | 1 | HKEx | ||
| 25.10. | HAOHAI BIOTEC (06826): WORKING RULES OF THE AUDIT COMMITTEE OF THE BOARD | - | HKEx | ||
| 25.10. | HAOHAI BIOTEC (06826): 2024 THIRD QUARTERLY REPORT; AMENDMENTS TO THE WORKING RULES OF THE STRATEGY COMMITTEE AND THE AUDIT COMMITTEE; AND CHANGE OF NAME ... | 3 | HKEx | ||
| 15.10. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | - | HKEx | ||
| 10.10. | HAOHAI BIOTEC (06826): ANNOUNCEMENT ON ADJUSTMENT OF SHARE PRICE CAP FOR REPURCHASE OF A SHARES | 1 | HKEx | ||
| 20.09. | Dividendenbekanntmachungen (20.09.2024) | 6.183 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECON GROUP INC CA00762V1094 0,19 CAD 0,1255 EUR ALEXANDER & BALDWIN INC US0144911049 0,2225 USD 0,1993 EUR ALLEGION PLC IE00BFRT3W74 0... ► Artikel lesen | |
| 19.09. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 13.09. | HAOHAI BIOTEC (06826): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024 (UPDATED) | 1 | HKEx | ||
| 13.09. | HAOHAI BIOTEC (06826): ARTICLES OF ASSOCIATION | 1 | HKEx | ||
| 13.09. | HAOHAI BIOTEC (06826): POLL RESULTS OF EGM, A SHAREHOLDERS' CLASS MEETING AND H SHAREHOLDERS' CLASS MEETING, AND 2024 INTERIM PROFIT DISTRIBUTION PLAN | 1 | HKEx | ||
| 05.09. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 02.09. | HAOHAI BIOTEC (06826): (REVISED) NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 02.09. | HAOHAI BIOTEC (06826): INTERIM REPORT 2024 | 2 | HKEx | ||
| 27.08. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 23.08. | HAOHAI BIOTEC (06826): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024 (UPDATED) | - | HKEx |
Seite:
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 2,070 | -2,73 % | Valneva mit Shigella-News: Bringt das die Wende? | Die Valneva Aktie erhielt gestern dringend benötigte Impulse, nachdem sie zuletzt tief gefallen war und zwei Tage in Folge Tagestiefs bei 2,232 bzw. 2,240 Euro markierte. Gestern konnte die Aktie im... ► Artikel lesen | |
| AMGEN | 269,45 | -1,37 % | Dividendenbekanntmachungen (18.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0569 EUR ALGOMA CENTRAL CORPORATION CA0156441077 0,19 CAD 0,128 EUR ALLISON TRANSMISSION... ► Artikel lesen | |
| STRYKER | 367,00 | +0,27 % | Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment | PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 700,20 | -0,71 % | Sanofi, Regeneron's Dupixent SBLA Accepted For FDA Review To Treat Chronic Spontaneous Urticaria | PARIS (dpa-AFX) - French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration has accepted for review the resubmission... ► Artikel lesen | |
| EXACT SCIENCES | 49,840 | -0,40 % | Exact Sciences ramps up colon cancer outreach to Hispanic community with Carlos Ponce partnership | ||
| CSL | 169,82 | +1,91 % | Is CSL the best ASX 100 share to buy now? | ||
| CANSINO BIOLOGICS | 3,480 | -5,95 % | CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR HAEMOPHILUS INFLUENZAE ... | ||
| BEIGENE LTD ADR | 180,00 | -2,70 % | BeiGene, Ltd.: BeiGene kündigt geplante Namensänderung in BeOne Medicines an und bekräftigt damit seine Mission, die globale Gemeinschaft im Kampf gegen Krebs zu vereinen | Der neue Name spiegelt die kühne Vision des Unternehmens wider, Krebs durch die Nutzung der transformativen Kraft globaler Zusammenarbeit und multisektoraler Partnerschaften auszurotten ... ► Artikel lesen | |
| BIOMERIEUX | 98,15 | +0,20 % | QVance AB Announces Nordic Partnership with bioMérieux | ||
| SINO BIOPHARM | 0,422 | -0,28 % | SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW INDICATION APPLICATION FOR MARKETING OF ANLOTINIB HYDROCHLORIDE CAPSULE IN COMBINATION ... | ||
| ZAI LAB LTD ADR | 24,800 | -0,80 % | Zai Lab Prices Public Offering Of About 7.84 Mln ADSs At US$25.50/ADS | BEIJING (dpa-AFX) - Zai Lab Limited (ZLAB) announced the pricing of its underwritten public offering of about 7.84 million American depositary shares, each representing ten ordinary shares of... ► Artikel lesen | |
| CSTONE PHARMACEUTICALS | 0,240 | -1,64 % | CSTONE PHARMA-B (02616): VOLUNTARY ANNOUNCEMENT - CSTONE AND PHARMALINK ENTER INTO STRATEGIC PARTNERSHIP FOR SUGEMALIMAB IN MIDDLE EAST AND NORTH AFRICA ... | ||
| CASI PHARMACEUTICALS | 5,200 | +2,97 % | CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results | BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development... ► Artikel lesen | |
| GENSCRIPT BIOTECH | 1,280 | 0,00 % | GENSCRIPT BIO (01548): GRANT OF RESTRICTED SHARES | ||
| 3SBIO | 0,640 | -1,54 % | 3SBIO (01530): VOLUNTARY ANNOUNCEMENT - MANDI RANKED THE FIRST PLACE ON MULTIPLE PLATFORMS IN "DOUBLE 11" OF 2024 |
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell +1,81 % bei einem Aktienkurs von 3,380 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD finden Sie auf Wallstreet Online.
